UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042921
Receipt number R000048903
Scientific Title Measurement of salivary pH while chewing gum containing acidulant. -2 step crossover single blind controlled trial-
Date of disclosure of the study information 2021/01/06
Last modified on 2021/07/08 10:25:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Measurement of salivary pH while chewing gum containing acidulant.

Acronym

Effect of gum acidulant on saliva pH.

Scientific Title

Measurement of salivary pH while chewing gum containing acidulant. -2 step crossover single blind controlled trial-

Scientific Title:Acronym

Measurement of salivary pH while chewing gum containing acidulant.

Region

Japan


Condition

Condition

Healthy volunteers

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether gum containing acidulant lowers salivary pH during chewing below 5.7.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Salivary pH

Key secondary outcomes

Salivary weight


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

6

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single intake of the gum 1 containing acidulant.

Interventions/Control_2

Single intake of the gum 2 containing acidulant.

Interventions/Control_3

Single intake of the gum 3 containing acidulant.

Interventions/Control_4

Single intake of the gum 4 containing acidulant.

Interventions/Control_5

Single intake of the gum 5 containing acidulant.

Interventions/Control_6

Single intake of the gum 6 containing acidulant.

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Males and females whose age is between 20 and 60 years old
2) Subjects who can prohibit themselves from taking alcohol on the day before trial
3) Subjects who can sleep enough on the day before trial and keep their regular conditions

Key exclusion criteria

1) Female subjects who are pregnant or lactating, or intending to become pregnant during the study
2) Subjects who have the possibility of developing allergic symptoms by the test food
3) Subjects who have a fever or complain of illness
4) Subjects who have difficulty chewing gum ordinarily (80 times/min)
5) Subjects who have meal or snack within 1 hour before the trial starts
6) Subjects who have a potential of Sjogren's syndrome (whose salivary flow late is below 1 mL/min)

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Satoko
Middle name
Last name Okuyama

Organization

LOTTE Co., Ltd.

Division name

Central Laboratory Basic Research Department Health Science Section

Zip code

336-8601

Address

3-1-1, Numakage, Minami-ku, Saitama

TEL

048-837-0170

Email

okuyama_satoko@lotte.co.jp


Public contact

Name of contact person

1st name Shouta
Middle name
Last name Satou

Organization

LOTTE Co., Ltd.

Division name

Central Laboratory Health Basic Research Department Science Section

Zip code

336-8601

Address

3-1-1, Numakage, Minami-ku, Saitama

TEL

048-837-0170

Homepage URL


Email

satou_shouta@lotte.co.jp


Sponsor or person

Institute

LOTTE Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

LOTTE Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Shiba Palace clinic

Address

DaiwaA Hamamatsucho Building 6F, 1-9-10 Hamamatsucho, Minato-ku, Tokyo

Tel

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社ロッテ中央研究所(埼玉県)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 12 Month 01 Day

Date of IRB

2020 Year 12 Month 28 Day

Anticipated trial start date

2021 Year 01 Month 09 Day

Last follow-up date

2021 Year 03 Month 11 Day

Date of closure to data entry

2021 Year 03 Month 11 Day

Date trial data considered complete

2021 Year 03 Month 11 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 06 Day

Last modified on

2021 Year 07 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048903


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name